Elpiscience (Suzhou) Biopharma
Elpiscience (Suzhou) Biopharma is a China-based biotechnology company running 2 late-stage cancer trials of ES014 and ES102 in desmoid tumour and non-small-cell lung cancer.
Overview
Elpiscience (Suzhou) Biopharma, based in Suzhou, China, is a biotechnology company. Elpiscience is a biopharmaceutical company developing immunotherapies for oncology and autoimmune disease. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing ES014 and ES102 in desmoid tumour and non-small-cell lung cancer. The largest, NCT07541430 (A Study in Adults With Desmoid Tumours), plans to enrol 50 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanyAvistone Biotechnology
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyMaia Biotechnology
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanySTCube
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyCivaTech Oncology
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyKrystal Biotech
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanymAbxience Research S.L.
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyCelltrion
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyCatalYm
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.